The Effect of Red Ginseng Extract on Inflammatory Cytokines after Chemotherapy in Children

  • Lee, Jae-Min (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Hah, Jeong-Ok (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Kim, Hee-Sun (Department of Microbiology, Yeungnam University College of Medicine)
  • Received : 2012.06.07
  • Accepted : 2012.08.28
  • Published : 2012.10.15


Ginseng has been used as an herbal medicine, widely used in Asian countries, for long time. Recently, beneficial effects for immune functions of Korean red ginseng (KRG) have been reported in adults. This study was performed to investigate the effects of ginseng on immune functions in children after cessation of chemotherapy or stem cell transplantation for advanced cancer. Thirty patients, who were diagnosed and treated for leukemia and solid cancer at the department of pediatrics and adolescence of the Yeungnam University Hospital from June 2004 to June 2009, were enrolled for the study. The study group consisted of 19 patients who received KRG extract (60 mg/kg/d) for 1 yr and 11 patients who did not receive KRG extract were the control group. Blood samples were collected every 6 mo. Immune assays included circulating lymphocyte subpopulation, serum cytokines (IL-2, IL-10, IL-12, TNF-alpha, and IFN-gamma), and total concentrations of serum IgG, IgA, and IgM subclasses. Age at diagnosis ranged from 2 mo to 15 yr (median 5 yr). Nine patients received stem cell transplantation. The cytokines of the KRG treated group were decreasing more rapidly than that of the control group. Lymphocyte subpopulations (T cell, B cell, NK cell, T4, T8, and T4/T8 ratio) and serum immunoglobulin subclasses (IgG, IgA, and IgM) did not show significant differences between the study and the control groups. This study suggests that KRG extract might have a stabilizing effect on the inflammatory cytokines in children with cancer after chemotherapy.



Supported by : Yeungnan University


  1. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994;84:2221-2228.
  2. Borella L, Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res 1971;31:420-426.
  3. Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69:1481-1486.<1481::AID-CNCR2820690628>3.0.CO;2-L
  4. Pasino M, Vadala CR, De Bernardi B, Comelli A, Mori PG, Dini G, Bisogni MC, Tonini GP, Massimo L. Immunological evaluation of 22 patients with acute lymphoblastic leukemia off-therapy. A longitudinal follow-up. Helv Paediatr Acta 1981;36:69-80.
  5. De Vaan GA, van Munster PJ, Bakkeren JA. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood. Eur J Pediatr 1982;139:113-117.
  6. Mustafa MM, Buchanan GR, Winick NJ, McCracken GH, Tkaczewski I, Lipscomb M, Ansari Q, Agopian MS. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998;20:451-457.
  7. Alanko S, Salmi TT, Pelliniemi TT. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1994;11:281-292.
  8. Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Pediatr Oncol 1995;24:373-378.
  9. Kim DH. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Ginseng Res 2012;36:1-15.
  10. Ernst E. Panax ginseng: An overview of the clinical evidence. J Ginseng Res 2010;34:259-263.
  11. Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:222-226.
  12. Cheng JT. Merit of ginseng in the improvement of insulin resistance. J Ginseng Res 2010;34:155-159.
  13. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 1996;22:65-72.
  14. Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res 1990;16:537-542.
  15. The Korea Central Cancer Registry, National Cancer Center. 2008 Annual report of cancer statistics in Korea. Seoul: Ministry of Health and Welfare, 2010.
  16. Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, Gurney JG, Donaldson SS, Leisenring WM, Robison LL et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2008;26:4401-4409.
  17. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
  18. Plevova P. Radiotherapy- and chemotherapy-induced normal tissue damage. Radiol Oncol 2002;36:109-119.
  19. Mazur B, Mertas A, Sonta-Jakimczyk D, Szczepanski T, Janik-Moszant A. Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy. Hematol Oncol 2004;22:27-34.
  20. Martin K, Viera K, Petr C, Marie N, Eva T. Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique and of probabilities of measurable concentrations of interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occurring in plasma of healthy blood donors. Mediators Inflamm 2006;2006:65237.
  21. Berdat PA, Wehrle TJ, Kung A, Achermann F, Sutter M, Carrel TP, Nydegger UE. Age-specific analysis of normal cytokine levels in healthy infants. Clin Chem Lab Med 2003;41:1335-1339.
  22. Hamza T, Barnett JB, Li B. Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 2010;11:789-806.
  23. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-189.
  24. Niederwieser D, Herold M, Woloszczuk W, Aulitzky W, Meister B, Tilg H, Gastl G, Bowden R, Huber C. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 1990;50:620-625.
  25. Kim SK, Park JH. Trends in ginseng research in 2010. J Ginseng Res 2011;35:389-398.
  26. Park EK, Choo MK, Kim EJ, Han MJ, Kim DH. Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull 2003;26:1581-1584.
  27. Park JS, Shin JA, Jung JS, Hyun JW, Van Le TK, Kim DH, Park EM, Kim HS. Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice. J Pharmacol Exp Ther 2012;341:59-67.
  28. Wang L, Zhang Y, Chen J, Li S, Wang Y, Hu L, Wang L, Wu Y. Immunosuppressive effects of ginsenoside-Rd on skin allograft rejection in rats. J Surg Res 2012;176:267-274.
  29. Wu CF, Bi XL, Yang JY, Zhan JY, Dong YX, Wang JH, Wang JM, Zhang R, Li X. Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int Immunopharmacol 2007;7:313-320.
  30. Smolinski AT, Pestka JJ. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb1 (ginseng) and parthenolide (feverfew). Food Chem Toxicol 2003;41:1381-1390.
  31. Xu X, Ling Q, Wei Q, Wang K, Zhou B, Zhuang L, Zhou L, Zheng S. Korean red ginseng: a new approach for the treatment of graft-versus-host disease after liver transplantation. Transplant Proc 2011;43:2651-2655.
  32. Suh SO, Boo YJ, Park JM, Kim J. Prospective study for Korean red ginseng extract as an immune modulator following a curative surgery in patients with advanced colon cancer. J Ginseng Res 2007;31:54-59.
  33. Kim S, Shim S, Choi DS, Kim JH, Kwon YB, Kwon J. Modulation of LPS-stimulated astroglial activation by ginseng total saponins. J Ginseng Res 2011;35:80-85.
  34. Kim EH, Lee MJ, Kim IH, Pyo SN, Choi KT, Rhee DK. Anti-apoptotic effects of red ginseng on oxidative stress induced by hydrogen peroxide in SK-N-SH cells. J Ginseng Res 2010;34:138-144.

Cited by

  1. Korean Red Ginseng Extract Enhances the Anticancer Effects of Imatinib Mesylate Through Abrogation p38 and STAT5 Activation in KBM-5 Cells vol.29, pp.7, 2015,
  2. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer vol.9, pp.1, 2015,
  3. White ginseng extract induces immunomodulatory effects via the MKK4-JNK pathway vol.25, pp.6, 2016,
  4. Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines vol.95, pp.44, 2016,
  5. Korean Red Ginseng Extract Enhances the Anticancer Effects of Sorafenib through Abrogation of CREB and c-Jun Activation in Renal Cell Carcinoma vol.31, pp.7, 2017,
  6. Interferon- γ -Mediated Natural Killer Cell Activation by an Aqueous Panax ginseng Extract vol.2015, pp.None, 2012,
  7. Modulation of cytokine production from cultured mononuclear cells of leukemia patients by Hypericum triquetrifolium Turra methanolic extract vol.25, pp.1, 2012,
  8. 소아암의 한의약치료 임상 동향 - 대조군 임상연구를 중심으로 vol.24, pp.2, 2012,
  9. Inhibition of Alveolar Bone Destruction by Red Ginseng Extract in an Experimental Animal Periodontitis Model vol.50, pp.7, 2021,